Tectonic Therapeutic (TECX) Operating Leases (2022 - 2026)

Tectonic Therapeutic (TECX) reported Operating Leases of $3.2 million for Q1 2026, up 2325.76% quarter-over-quarter from $132000.0 in Q4 2024.

Tectonic Therapeutic (TECX) Operating Leases (2022 - 2026) Analysis & Trends

Tectonic Therapeutic (TECX) has 4 years of Operating Leases data on file, last reported at $3.2 million in Q1 2026.

  • Operating Leases for Q1 2026 came in at $3.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 million (changed N/A YoY), and the FY2024 annual result was $132000.0, down 91.97% from the prior year.
  • Operating Leases rose to $3.2 million in Q1 2026 per TECX's latest filing, from $132000.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $3.2 million in Q1 2026 and troughed at $132000.0 in Q4 2024.
  • A 4-year average of $1.2 million and a median of $905000.0 in 2024 frame the typical range for Operating Leases.
  • The sharpest annual moves came in 2023 and 2024: Operating Leases jumped 774.47% in 2023, then sank 91.97% in 2024.
  • A 4-year view of Operating Leases shows it stood at $188000.0 in 2022, then jumped by 774.47% to $1.6 million in 2023, then slumped by 91.97% to $132000.0 in 2024, then jumped by 2325.76% to $3.2 million in 2026.
  • Business Quant data shows TECX's Operating Leases at $3.2 million in Q1 2026, $132000.0 in Q4 2024, and $523000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Tectonic Therapeutic 528.16 Mn 291.27 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.20 Mn
Dec 31, 2024 132,000.00
Sep 30, 2024 523,000.00
Jun 30, 2024 905,000.00
Dec 31, 2023 1.64 Mn
Sep 30, 2023 1.75 Mn
Jun 30, 2023 2.38 Mn
Mar 31, 2023 352,000.00
Dec 31, 2022 188,000.00